Cardiovascular Health

July 07, 2020

Rheumatoid arthritis patients have nearly a double risk of atherosclerotic CVD, stroke, heart failure and atrial fibrillation, but they receive poorer primary and secondary preventive care than other high-risk patients. Learn more in this summary of a review published in Nature Reviews Rheumatology.

June 02, 2020

Researchers writing in Arthritis and Rheumatology report that high levels of anti-citrullinated protein antibodies (anti-CCP2) appear to be markers for future cardiovascular events in rheumatoid arthritis patients.

January 22, 2020

Rheumatoid arthritis patients have an increased risk of developing cardiovascular disease, yet rheumatologists and primary care physicians who treat RA patients sometimes miss the signs and symptoms of CVD in their patients. Learn more in this slideshow.

September 26, 2019

Postmenopausal women with early rheumatoid arthritis have a metabolic syndrome profile similar to men and should equally be considered high risk for the development of cardiovascular disease, according to Bindee Kuriya M.D, writing in the journal ACR Open Rheumatology.

September 23, 2019

Taking calcium supplements doesn't appear to worsen cardiovascular health in healthy postmenopausal women, according to a study presented at the American Society for Bone and Mineral Research annual meeting that took place over the weekend.

September 16, 2019

Nonsteroidal anti-inflammatory drug (NSAID) use contributes substantially to the increased risk of cardiovascular disease among patients with osteoarthritis, say researchers writing in Arthritis & Rheumatology last month.

August 27, 2019

Patients diagnosed with gout at age 40 or younger may be at increased risk for cardiovascular disease and recurrent gout compared to those diagnosed later in life, according to a new study published in ACR Open Rheumatology.

July 15, 2019

While gout does not increase the risk of death post-acute coronary syndrome, a new study suggests it may increase an individual’s risk for readmission after heart failure, as well as the number of days he or she will spend on the hospital.

July 08, 2019

The presence of carotid atherosclerosis in psoriasis and psoriatic arthritis patients is associated with an increased risk of having a cardiovascular event, researchers report.

June 20, 2019

While gout does not increase the risk of death post-acute coronary syndrome, a new study shows the condition does increase an individual’s risk for readmission after heart failure, as well as the number of days he or she will spend on the hospital.

April 11, 2019

In this slideshow, we highlight some recent noteworthy advances in rheumatology, including new developments on the benefits of chiropractic care, how best to adopt methotrexate into a treatment plan, a possible new benefit for fatty acids, and much more.

April 09, 2019

Study shows there is no substantial difference in cardiovascular risk associated with different biologic therapies for psoriasis and psoriatic arthritis patients.

January 23, 2019

(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.

December 19, 2018

Canadian researchers looked at the safety of short-term use in patients with hypertension, heart failure, or chronic kidney disease.

August 23, 2018

Findings from one of the few studies that have looked at the risk of arrhythmias related to gout in elderly patients.

July 17, 2018

How high is the risk of CV disease in RA? What rare but serious complications can rheumatoid vasculitis cause? Answers here.

July 09, 2018

Two recent studies focus on the risks of osteoporosis and cardiovascular disease in patients on the psoriatic arthritis/psoriasis spectrum.

May 31, 2018

Which organs are most commonly affected? What’s the impact of RA therapies on comorbidities? Answers here.

April 16, 2018

Here: the latest evidence on the effects of febuxostat, allopurinol, and statins on CV mortality in patients with gout.

April 10, 2018

A study sheds new light on the extra-articular manifestations of spondyloarthritis-with a focus on the heart as a high-risk target.